Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.
Saved in:
| Title: | Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. |
|---|---|
| Authors: | Newell F; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Cancer Centre, Blacktown Hospital, Sydney, NSW 2148, Australia., Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Addala V; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia; Department of Medical Oncology, Westmead Hospital, Sydney, NSW 2145, Australia., Rizos H; Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, NSW 2109, Australia., Nones K; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Edwards JJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Lakis V; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Kazakoff SH; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Mukhopadhyay P; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW 2050, Australia., Leonard C; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Koufariotis LT; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Wood S; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Blank CU; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Pearson JV; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia; John Curtin School of Medical Research, Australian National University, ACT 2601, Australia., Hayward NK; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW 2050, Australia., Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia. Electronic address: georgina.long@melanoma.org.au. |
| Source: | Cancer cell [Cancer Cell] 2022 Jan 10; Vol. 40 (1), pp. 88-102.e7. Date of Electronic Publication: 2021 Dec 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34951955 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Newell+F%22">Newell F</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Pires+da+Silva+I%22">Pires da Silva I</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Cancer Centre, Blacktown Hospital, Sydney, NSW 2148, Australia.<br /><searchLink fieldCode="AU" term="%22Johansson+PA%22">Johansson PA</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia.<br /><searchLink fieldCode="AU" term="%22Wilmott+JS%22">Wilmott JS</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Addala+V%22">Addala V</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Carlino+MS%22">Carlino MS</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia; Department of Medical Oncology, Westmead Hospital, Sydney, NSW 2145, Australia.<br /><searchLink fieldCode="AU" term="%22Rizos+H%22">Rizos H</searchLink>; Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, NSW 2109, Australia.<br /><searchLink fieldCode="AU" term="%22Nones+K%22">Nones K</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Edwards+JJ%22">Edwards JJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Lakis+V%22">Lakis V</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Kazakoff+SH%22">Kazakoff SH</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Mukhopadhyay+P%22">Mukhopadhyay P</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Ferguson+PM%22">Ferguson PM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Leonard+C%22">Leonard C</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Koufariotis+LT%22">Koufariotis LT</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Wood+S%22">Wood S</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Blank+CU%22">Blank CU</searchLink>; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Thompson+JF%22">Thompson JF</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Spillane+AJ%22">Spillane AJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia.<br /><searchLink fieldCode="AU" term="%22Saw+RPM%22">Saw RPM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Shannon+KF%22">Shannon KF</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Pearson+JV%22">Pearson JV</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Mann+GJ%22">Mann GJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia; John Curtin School of Medical Research, Australian National University, ACT 2601, Australia.<br /><searchLink fieldCode="AU" term="%22Hayward+NK%22">Hayward NK</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Scolyer+RA%22">Scolyer RA</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Waddell+N%22">Waddell N</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia. Electronic address: georgina.long@melanoma.org.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2022 Jan 10; Vol. 40 (1), pp. 88-102.e7. <i>Date of Electronic Publication: </i>2021 Dec 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34951955 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ccell.2021.11.012 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 88 Titles: – TitleFull: Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Newell F – PersonEntity: Name: NameFull: Pires da Silva I – PersonEntity: Name: NameFull: Johansson PA – PersonEntity: Name: NameFull: Menzies AM – PersonEntity: Name: NameFull: Wilmott JS – PersonEntity: Name: NameFull: Addala V – PersonEntity: Name: NameFull: Carlino MS – PersonEntity: Name: NameFull: Rizos H – PersonEntity: Name: NameFull: Nones K – PersonEntity: Name: NameFull: Edwards JJ – PersonEntity: Name: NameFull: Lakis V – PersonEntity: Name: NameFull: Kazakoff SH – PersonEntity: Name: NameFull: Mukhopadhyay P – PersonEntity: Name: NameFull: Ferguson PM – PersonEntity: Name: NameFull: Leonard C – PersonEntity: Name: NameFull: Koufariotis LT – PersonEntity: Name: NameFull: Wood S – PersonEntity: Name: NameFull: Blank CU – PersonEntity: Name: NameFull: Thompson JF – PersonEntity: Name: NameFull: Spillane AJ – PersonEntity: Name: NameFull: Saw RPM – PersonEntity: Name: NameFull: Shannon KF – PersonEntity: Name: NameFull: Pearson JV – PersonEntity: Name: NameFull: Mann GJ – PersonEntity: Name: NameFull: Hayward NK – PersonEntity: Name: NameFull: Scolyer RA – PersonEntity: Name: NameFull: Waddell N – PersonEntity: Name: NameFull: Long GV IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 01 Text: 2022 Jan 10 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1878-3686 Numbering: – Type: volume Value: 40 – Type: issue Value: 1 Titles: – TitleFull: Cancer cell Type: main |
| ResultId | 1 |